Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Laryngoscope. 2012 Mar 27;122(7):1539–1544. doi: 10.1002/lary.23266

Figure 2.

Figure 2

In vitro proliferation of endothelial cells (HUVEC) and fibroblasts (HS27) relative to controls following treatment with FGFR inhibitor (PD173074) for 72 hrs. (unpaired t-test; *p<0.05, **p<0.01).